| NSW | Vic | WA | SA | Tas 1 | ACT | NT | Commonwealth 2 | NZ | |
|---|---|---|---|---|---|---|---|---|---|
Chemical agents | |||||||||
| Alcohols, glycols or ketones | N/A | N/A | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | N/A | Poisoning by alcohols, glycols or ketones | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Schedule 1 - Diseases related to employment | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis, irritant contact dermatitis, allergic contact dermatitis. | N/A |
| Antimony | N/A | N/A | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | Antimony poisoning or its sequelae (antimony or its preparations or compounds). | Acute poisoning or toxicity. | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis. | N/A |
| Arsenic | Arsenic poisoning by arsenic or its compounds, and its sequelae (Schedule 1 Workers’ Compensation Regulation 2016) | Arsenic poisoning or its sequelae (arsenic or its preparations or compounds) | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood Primary malignant disease of the lung Peripheral neuropathy | Arsenic poisoning or its sequelae (arsenic or its preparations or compounds) | Acute poisoning or toxicity by arsenic | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Lung Malignancy Peripheral neuropathy | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood), Lung malignancy Peripheral neuropathy | May include peripheral neuropathy, non-infectious hepatitis. | Diseases of a type generally accepted by the medical profession as caused by arsenic or its toxic compounds |
| Asphyxiants: carbon monoxide, hydrogen sulphide, hydrogen cyanide | N/A | Carbon monoxide poisoning | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | Carbon monoxide poisoning or its sequelae | Acute poisoning or toxicity by chemical asphyxiants (including, but not limited to, carbon monoxide, hydrogen cyanide, hydrogen sulphide and methylene chloride), | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis. | N/A |
| Benzene | Poisoning by benzene or its homologues, their nitro and amido- derivatives, and its sequelae (Schedule 1 Workers’ Compensation Regulation 2016) | Poisoning by benzol, its homologues, or its nitro and amido- derivatives, and the sequelae of these poisonings | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood Primary leukaemia | Benzene poisoning (i.e. poisoning by benzene or its homologues or their nitro and amido-derivatives) and its sequelae | Acute poisoning or toxicity by benzene | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Leukaemia (excluding chronic lymphatic leukaemia) | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Malignancy - Leukaemia (excluding chronic lymphatic leukaemia) | May include primary leukaemia, non-infectious hepatitis. | Diseases of a type generally accepted by the medical profession as caused by benzene or its toxic homologues |
| Beryllium | N/A | N/A | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood Primary malignant disease of the lung | N/A | Acute poisoning or toxicity by beryllium | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Other Pneumoconiosis Malignancy - Lung | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Respiratory diseases - Other Pneumoconiosis Malignancy - Lung | May include pneumoconiosis, non-infectious hepatitis. | Diseases of a type generally accepted by the medical profession as caused by beryllium or its toxic compounds |
| Cadmium | N/A | N/A | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood Primary malignant disease of the lung | N/A | Acute poisoning or toxicity by cadmium | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Malignancy - Lung | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Malignancy - Lung | May include non-infectious hepatitis. | Chronic renal failure diagnosed as caused by metals such as cadmium or copper, including via welding fumes |
| Carbon disulphide | N/A | Carbon bisulphide poisoning | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood Peripheral neuropathy | N/A | Acute poisoning or toxicity by carbon disulphide | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Peripheral neuropathy | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Diseases of the Nervous System - Peripheral neuropathy | May include non-infectious hepatitis and peripheral neuropathy. | Diseases of a type generally accepted by the medical profession as caused by carbon bisulfide or its toxic compounds |
| Chromium | N/A | Chrome ulceration or its sequelae (chromic acid, bichromate of ammonium, potassium or sodium or their preparations) | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood Primary malignant disease of the lung | Chrome ulceration or its sequelae (chromic acid, bichromate of ammonium, potassium or sodium or their preparations) | Acute poisoning or toxicity by chromium | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Lung Malignancy – Chromium VI | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Malignancy - Lung (chromium VI) | May include occupational asthma and non-infectious hepatitis. | Diseases of a type generally accepted by the medical profession as caused by chrome or its toxic compounds |
| Copper | N/A | Copper poisoning or its sequelae (copper or its preparations or compounds) | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | Copper poisoning or its sequelae (copper or its preparations or compounds) | Acute poisoning or toxicity | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis. | Chronic renal failure diagnosed as caused by metals such as cadmium or copper, including via welding fumes |
| Ethylene oxide | N/A | N/A | Occupational asthma | N/A | N/A | N/A | N/A | May include occupational asthma. | Diseases of a type generally accepted by the medical profession as caused by ethylene oxide |
| Fluorine | N/A | N/A | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | N/A | Acute poisoning or toxicity by fluorine | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis, occupational asthma. | N/A |
| Halogen derivatives of aliphatic or aromatic hydrocarbons | Poisoning by the halogen derivates of hydrocarbons of the aliphatic series (Schedule 1 Workers’ Compensation Regulation 2016) | Poisoning by the halogen derivates of hydrocarbons of the aliphatic series | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | Halogen poisoning (i.e.: poisoning by the halogen derivatives of hydrocarbons of the aliphatic series) and its sequelae | Acute poisoning or toxicity by toxic halogen derivatives, aliphatic or aromatic hydrocarbons | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis. | Diseases of a type generally accepted by the medical profession as caused by the toxic halogen derivatives of hydrocarbons of the aliphatic series |
| Lead | Poisoning by lead, its alloys or compounds, and its sequelae. (Schedule 1 Workers’ Compensation Regulation 2016) | Lead poisoning or its sequelae (lead or its preparations or compounds). | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood Peripheral neuropathy | Lead poisoning or its sequelae (lead or its preparations or compounds). | Acute poisoning or toxicity by lead. | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Peripheral neuropathy | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Diseases of the Nervous System - Peripheral neuropathy | May include peripheral neuropathy, non-infectious hepatitis. | Diseases of a type generally accepted by the medical profession as caused by lead or its toxic compounds |
| Manganese | N/A | N/A | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | N/A | Acute poisoning or toxicity by manganese | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Parkinson’s Disease | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Diseases of the Nervous System - Parkinson’s disease | May include Parkinson’s Disease, non-infectious hepatitis. | Diseases of a type generally accepted by the medical profession as caused by manganese or its toxic compounds |
| Mercury | Poisoning by mercury or its amalgams or compounds, and its sequelae (Schedule 1 Workers’ Compensation Regulation 2016) | Mercury poisoning or its sequelae (mercury or its preparations or compounds) | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood Peripheral neuropathy | Mercury poisoning or its sequelae (mercury or its preparations or compounds) | Acute poisoning or toxicity by mercury. | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Peripheral neuropathy | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) Diseases of the Nervous System - Peripheral neuropathy | May include peripheral neuropathy, non-infectious hepatitis. | Diseases of a type generally accepted by the medical profession as caused by mercury or its toxic compounds |
| Nitro and amino- derivatives of benzene | Poisoning by benzene or its homologues, their nitro and amido- derivatives, and its sequelae (Schedule 1 Workers’ Compensation Regulation 2016) | Poisoning by benzol, its homologues, or its nitro and amido derivatives, and the sequelae of these poisonings | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blooD | Benzene poisoning (i.e. poisoning by benzene or its homologues or their nitro and amdio-derivatives) and its sequelae | Acute poisoning or toxicity by toxic nitro-derivatives and amino-derivatives of benzene | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis. | Diseases of a type generally accepted by the medical profession as caused by nitro and amido- toxic derivatives of benzene or its homologues |
| Nitroglycerine or other nitric acid esters | N/A | N/A | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | N/A | Acute poisoning or toxicity by nitroglycerine or other nitric acid esters | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis. | N/A |
| Organic solvents | N/A | N/A | Peripheral neuropathy Non-infectious hepatitis | N/A | N/A | Peripheral neuropathy Non-infectious hepatitis | Diseases of the Nervous System - Peripheral neuropathy Hepatic Diseases - Non-infectious hepatitis | May include irritant contact dermatitis. | Chronic solvent-induced encephalopathy diagnosed as caused by organic solvents, particularly styrene, toluene, xylene, trichloroethylene, methylene chloride or white spirit Peripheral neuropathy diagnosed as caused by organic solvents such as n-hexane, carbon disulphide, or trichloroethylene, pesticides such as organophosphates; acrylamide |
| Oxides of nitrogen | N/A | N/A | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | Nitrous fumes poisoning and its sequelae | Poisoning by nitrous fumes | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis. | N/A |
| Phosphorus | Phosphorus poisoning by phosphorous or its compounds, and its sequelae (Schedule 1 Workers’ Compensation Regulation 2016) | Phosphorous poisoning or its sequelae (phosphorous or its preparations or compounds) | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | Phosphorus poisoning or its sequelae (phosphorus or its preparations or compounds) | Acute poisoning or toxicity by phosphorus | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis. | Diseases of a type generally accepted by the medical profession as caused by phosphorus or its toxic compounds |
| Tungsten | N/A | N/A | N/A | N/A | N/A | Other pneumoconiosis | Respiratory Diseases - Other pneumoconiosis | May include pneumoconiosis, occupational asthma. | Diseases of a type generally accepted by the medical profession as caused by tungsten |
| Zinc | N/A | Zinc poisoning or its sequelae (zinc or its preparations or compounds) | Poisoning or toxicity causing acute damage to the heart, lungs, liver, kidney, nervous system or blood | Zinc poisoning or its sequelae (zinc or its preparations or compounds) | Acute poisoning or toxicity by zinc | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | Acute poisoning/toxicity (includes acute damage to the heart, lungs, liver, kidney, nervous system and blood) | May include non-infectious hepatitis, occupational asthma. | N/A |
| Other chemical agent at work not mentioned in the preceding terms | N/A | N/A | Exposure to any occupational agent including:
| Primary epitheliomatous cancer of the skin from work involving handling of tar, pitch, bitumen, mineral oil, paraffin or the compounds products or residues of those substances | Acute poisoning or toxicity by hexane, osmium, ozone, pesticides (including, but not limited to, organophosphate and organochlorine compounds, herbicides, and related compounds), pharmaceutical agents, phosgene, selenium, styrene, thallium, tin, toluene, vanadium, irritants (including, but not limited to, benzoquinone and other corneal irritants). | Acute Poisoning/toxicity - Employment involving exposure to acrylonitrile, hexane, mineral acids, osmium, ozone, pesticides consisting of organophosphate and organochlorine compounds, herbicides and related compounds, pharmaceutical agents, phosgene, selenium, styrene, thallium, tin, toluene, vanadium, chemical asphyxiants (for example methylene chloride), benzoquinone and other corneal irritants, and other less common, specific substances known to result in poisoning/toxicity that have not been named here Peripheral neuropathy employment involving exposure to metals, organic solvents, pesticides or acrylamide | 2-naphthylamine, acrylamide, crylonitrile, aluminium, barium, benzidine benzoquinone and other corneal irritants, bis(chloromethyl), ether, butadiene, cobalt, cyclophosphamide, formaldehyde, herbicides and related compounds, hexane, hydroquinone, iron oxide, methylene chloride), mineral acids, nickel, organic solvents (such as n-hexane and trichloroethylene), ortho-toluidine, osmium, ozone, para-amylphenol, para-tertiary-butylcatechol, para-tertiary-butylphenol, pesticides consisting of organophosphate and organochlorine compounds, pharmaceutical agents, phosgene, polychlorinated biphenyls, polycyclic aromatic hydrocarbons, radon-222 and its decay products, selenium, styrene, thallium, tin, toluene, tricholoroethylene, vanadium, vinyl chloride monomer and other less common, specific substances known to result in poisoning/toxicity that have not been named here. | N/A | N/A |
| Hearing impairment caused by noise | N/A | N/A | Noise induced hearing loss suffered by a worker due to the nature of employment with an employer s.108 | Noise induced hearing loss | Industrial deafness caused by workplace deafness S72A | Hearing impairment caused by noise above 85dB(A) Schedule 1 - Diseases related to employment | Disease of the Nervous System - Noise induced hearing loss - exposure to persistent or intermittent noise above 85dB(A) | N/A | N/A |
| Ionising radiations | Pathological manifestations of a kind that are due to or contributed to by:
(Schedule 1 Workers’ Compensation Regulation 2016) | Pathological manifestations due to radium and other radioactive substances, or X-rays | Primary leukaemia Primary malignant disease of the bladder Primary malignant disease of the bone Primary malignant disease of the brain Primary malignant disease of the breast (female) Primary malignant disease of the colon or rectum Primary malignant disease of the kidney Primary malignant disease of the lung Primary malignant disease of the nasal cavity or paranasal sinuses Primary malignant disease of the oesophagus Primary malignant disease of the salivary gland Primary malignant disease of the skin (non-melanoma) Primary malignant disease of the stomach Primary malignant disease of the thyroid Primary non-Hodgkin lymphoma | Pathological manifestations due to:
| Salivary gland cancer; Oesophagus cancer; Stomach cancer; Colon, or rectum, cancer; Nasal cavity, or paranasal sinuses, cancer; Lung cancer; Bone cancer; Skin cancer – non-melanoma; Breast cancer (female); Kidney cancer; Bladder cancer; Thyroid cancer; Leukaemia (other than chronic lymphatic leukaemia); Non-Hodgkin’s lymphoma. |
| Malignancy of:
| Employment for at least 5 years (whether consecutive or not) involving work with:
| Diseases of a type generally accepted by the medical profession as caused by ionising radiations |
| Vibration (disorders of muscles, tendons, bones, joints, peripheral blood vessels or peripheral nerves | N/A | N/A | Raynaud’s disease | N/A | Raynaud’s disease in workers’ in occupations involving vibrations from powered tools or equipment | Raynaud’s disease | Musculoskeletal Diseases - Raynaud’s disease | Raynaud’s diseases in workers employed for at least 12 weeks (whether consecutive or not) involving work with:
| Hand-arm vibration syndrome diagnosed as caused by hand and/or arm vibration |
| Work in compressed or decompressed air | N/A | N/A | Significantly increased or decreased air pressure including Osteonecrosis | N/A | Compressed air illness including avascular necrosis in workers’ exposed to increased or reduced atmospheric pressure (including, but not limited to, working underground or underwater and working at high altitude). | N/A | N/A | N/A | N/A |
| Diseases caused by other physical agents at work not mentioned in the preceding terms | N/A | N/A | Bursitis (at the elbow or knee) from employment for at least 6 months involving prolonged external friction or pressure or repetitive motion at or about the elbow or the knee. | N/A | Bursitis of the knee or elbow in workers employed in occupations involving prolonged external friction, pressure or repetitive motion at, or about, the elbow or knee | Bursitis at the elbow or knee employment involving prolonged external friction or pressure or repetitive motion at or about the elbow or the knee | Musculoskeletal Disease - Bursitis (at elbow or knee) - all work involving prolonged external friction pressure or repetitive motion at or about the elbow or the knee | N/A | N/A |
Biological agents and infectious or parasitic diseases | |||||||||
| Anthrax | Anthrax infection. (Schedule 1 Workers’ Compensation Regulation 2016) | Anthrax | Employment involving work with animals or animal carcasses (such as an animal handler, pelt handler, abattoir worker or meat inspector). | Anthrax | In workers’ in occupations involving work with animals or animal carcasses (including, but not limited to, animal handlers, pelt handlers, abattoir workers and meat inspectors). | employment involving work with animals or animal carcasses (for example employment as an animal handler, pelt handler, abattoir worker, or meat inspector) | Infectious Disease - Anthrax | Employment involving work with animals, animal carcasses, or animal parts. | Anthrax infection |
| Brucellosis | Brucellosis. (Schedule 1 Workers’ Compensation Regulation 2016) | Brucellosis (Undulant fever) | Employment involving work with animals or animal carcasses (such as a veterinarian, farmer or farm worker, abattoir worker or laboratory worker). | Brucellosis | In workers’ in occupations involving work with animals or animal carcasses (including, but not limited to, veterinarians, farmers or farm workers, abattoir workers and laboratory workers). NB: s25(2)(b) provides that compensation is not payable in respect of the disease known as undulant fever or brucellosis unless a medical practitioner has certified in writing that he is satisfied as to the result of the pathological examination of the blood that the worker is suffering from that disease. | employment involving work with animals or animal carcasses (for example employment as a veterinarian, farmer or farm worker, abattoir worker or laboratory worker) | Infectious Disease - Brucellosis | Employment involving work with animals, animal carcasses, animal parts, or animal waste | Brucellosis diagnosed as caused by working with animals or their carcasses |
| Hepatitis viruses | N/A | N/A | Hepatitis A Employment involving contact with human waste (such as a worker in rural or remote communities, child care worker, carer of a person with an intellectual disability, sewage worker or plumber). Hepatitis B or C Employment involving contact with human bodily secretions (such as a health care worker, embalmer, person who handles bodily substances, clinical laboratory worker, worker in long-term correctional facilities, police officer, member of the armed forces or emergency services worker). | N/A | Hepatitis A – For occupations involving contact with human waste (including, but not limited to, child care workers, carers of intellectually disabled persons, workers in rural or remote Indigenous communities, sewage workers and plumbers). Hepatitis B & C – For occupations involving contact with human bodily secretions (including, but not limited to, health care workers, embalmers, persons who handle body substances, clinical laboratory staff, workers in long-term correctional facilities, members of the police service, members of the armed forces and emergency services workers). | Hepatitis A employment involving contact with human waste Hepatitis B and C employment involving contact with human bodily secretions Non-infectious hepatitis - employment involving exposure to agents known to cause hepatitis Chronic active hepatitis - employment involving contact with human bodily secretions – for a person with known Hepatitis B Virus (HBV) or Hepatitis C Virus (HCV), where the HBV or HCV was contracted through the employment Hepatic cirrhosis - employment involving contact with human bodily secretions – for a person with known Hepatitis B Virus (HBV) or Hepatitis C Virus (HCV), where the HBV or HCV was contracted through the employment | Infectious Disease: Hepatitis A Hepatitis B and C | Employment involving work with human waste or bodily fluids. | N/A |
| Human immunodeficiency virus (HIV) | N/A | N/A | Health care workers and laboratory workers who become HIV infected after an injury caused by the use of a hypodermic needle or syringe. If a worker is infected with HIV by accident arising out of or in the course of employment or while the worker is acting under the employer’s instructions is taken to be a personal injury by accident. If the worker subsequently develops AIDS, the degree of permanent impairment is taken to be 100% | N/A | Health care workers or laboratory workers if the worker has become HIV positive after a needle-stick injury that occurs while at work. | health care worker or laboratory worker who becomes HIV positive after a needlestick injury | Infectious Disease - HIV/AIDS | Employment involving work with needles or sharps in a healthcare services setting | N/A |
| Leptospirosis | Leptospirosis. (Schedule 1 Workers’ Compensation Regulation 2016) | Leptospirosis | Employment involving work with animals or animal carcasses (such as a farmer or farm worker, abattoir worker, forestry worker, hunter, veterinarian or livestock transport operator) or work with animal or human waste (such as a plumber). | Leptospirosis | Occupations involving
| Employment involving work with animals or animal carcasses or work with animal or human waste. | Infectious Disease - Leptospirosis | Employment involving work with animals, animal carcasses, animal parts, or animal waste | Leptospirosis diagnosed as caused by working with animals or their carcasses |
| Diseases caused by other biological agents at work not mentioned in the preceding terms | Q fever. (Schedule 1 Workers’ Compensation Regulation 2016) | Q fever as caused by the micro-organism Coxiella burnetii (also known as Rickettsia burneti), in any of its clinical manifestations [abattoirs, slaughterhouses, knackeries]. Septic poisoning or its sequelae (from meat, meat products, animal products) | Schedule 1 Workers Compensation and Injury Management Regulations 2024 Avian Influenza COVID-19 Middle East Respiratory Syndrome Orf Psittacosis Q-fever Tuberculosis | Ankylostomiasis (mining). Q fever. Septic poisoning or its sequelae (from meat, meat manufacture, meat products, animal by-products with the trade of butcher or slaughterman) | Orf - Occupations involving work with sheep, goats or sheep or goat carcasses (including, but not limited to, sheep farmers or farm workers, goat farmers or farm workers, abattoir workers and meat inspectors).
| Q fever, Orf, Tuberculosis | Infectious Disease: Orf Q-fever Tuberculosis | Occupational infectious or parasitic diseases (health or laboratory work, veterinary work, handling of animals) | Orf diagnosed as caused by working with animals or their carcasses. Streptococcus suis diagnosed as caused by working with animals or their carcasses |
Respiratory Diseases | |||||||||
| Asthma caused by recognised sensitizing agents or irritants inherent to the work process | N/A | N/A | Occupational asthma Employment for at least 4 weeks involving exposure to sensitising agents or irritants such as arthropods or mites, biological enzymes, bioaerosols, flour, sensitising foods, flowers, latex, wood dusts, solder, reactive dyes, anhydrides, acrylates, epoxy, ethylene oxide, aldehydes, pesticides, amines, ammonia, industrial cleaning agents, acids, isocyanates, other reactive chemicals, sensitising metals, sensitising drugs or agents or irritants derived from fish/shellfish or other animals. | Asthma or asthmatic attacks (dust of red pine, western red cedar, blackwood, flour, flour dust) | Occupational asthma other than pre-existing asthma in workers exposure to sensitising agents or irritants (including, but not limited to, arthropods or mites, biological enzymes, bioaerosols, products derived from fish/shellfish/animal, flour, sensitising foods, flowers, latex, wood dusts, soldering, reactive dyes, anhydrides, acrylates, epoxy, ethylene oxide, aldehydes, pesticides, amines, ammonia, industrial cleaning agents, acids, isocyanates, other reactive chemicals, sensitising metals and sensitising drugs). | Occupational asthma (excluding pre-existing asthma worsened due to exposure to workplace irritants) | Respiratory Diseases - Occupational asthma (excluding pre-existing asthma worsened due to exposure to workplace irritants) | Employment for at least 4 weeks (whether consecutive or not) involving work with an agent or thing specified in column 2 of an item of the table in Schedule 2. | Occupational asthma diagnosed as caused by recognised sensitising agents inherent in the work process such as, but not limited to, isocyanates, certain wood dusts, flour dusts, animal proteins, enzymes and latex |
| Bronchopulmonary diseases caused by dust of cotton (byssinosis), flax, hemp, sisal or sugar cane | Byssinosis Bagassosis (Schedule 1 of the Workers’ Compensation (Dust Diseases) Act 1942) | N/A | Employment for at least 4 weeks involving exposure to dust from cotton, flax, hemp or sisal. | N/A | Byssinosis in workers exposed to cotton, flax, hemp or sisal dust. | Byssinosis employment involving exposure to cotton, flax, hemp or sisal dust | Respiratory Diseases Byssinosis | Employment for at least 4 weeks (whether consecutive or not) involving work with unprocessed cotton, unprocessed flax unprocessed hemp; or unprocessed sisal. | Byssinosis diagnosed as caused by working with cotton, flax, hemp, or sisal dust |
| Bronchopulmonary diseases caused by hard-metal dust | Hard metal pneumoconiosis (Schedule 1 of the Workers’ Compensation (Dust Diseases) Act 1942) | N/A | N/A | N/A | Other forms of pneumoconiosis in workers’ exposed to known causes of pneumoconiosis (including, but not limited to, beryllium, tin, iron oxide, barium, aluminium, cobalt and tungsten). | N/A | Respiratory Diseases - Other pneumoconiosis | Employment for at least 5 years (whether consecutive or not) involving work with aluminium, barium, beryllium, cobalt, iron oxide, tin or tungsten. | N/A |
| Chronic obstructive pulmonary diseases caused by inhalation of coal dust, dust from stone quarries, wood dust, dust from cereals and agricultural work, dust in animal stables, dust from textiles, and paper dust arising from work activities | Coal dust pneumoconiosis Farmer’s lung (Schedule 1 of the Workers’ Compensation (Dust Diseases) Act 1942) | N/A | Pneumoconiosis
| N/A | Coal workers’ pneumoconiosis in workers’ exposed to coal | Silicosis Coal workers’ Pneumoconiosis Byssinosis Malignancy: Nasopharynx Nasal cavity and para-nasal sinuses Lung | Respiratory Diseases Coal workers’ pneumoconiosis Silicosis Byssinosis Malignancy: Nasopharynx Nasal cavity and para-nasal sinuses Lung | Employment for at least 5 years (whether consecutive or not) involving work with material containing crystalline silica or silica. | Chronic obstructive pulmonary disease diagnosed as caused by coal, silica, cotton dust or grain dust |
| Diseases of the lung caused by aluminium | Aluminosis (Schedule 1 of the Workers’ Compensation (Dust Diseases) Act 1942) | N/A | N/A | N/A | See Occupational asthma and other forms of Pneumoconiosis above. | Other Pneumoconiosis | Respiratory Diseases - Other Pneumoconiosis | As above – hard metal dust. | N/A |
| Extrinsic allergic alveolitis caused by the inhalation of organic dusts or microbially contaminated aerosols | N/A | N/A | Employment for at least 4 weeks involving exposure to damp material of biological origin such as mouldy hay, straw, grain or feathers. | N/A | Extrinsic allergic alveolitis in workers’ exposed to damp material of biological origin (including, but not limited to, mouldy hay, straw, grain and feathers). | Extrinsic allergic alveolitis employment involving exposure to damp material of biological origin | Respiratory Diseases - Extrinsic allergic alveolitis – all work involving damp material of biological origin, such as mouldy hay, straw, grain and feathers | Employment for at least 4 weeks (whether consecutive or not) involving work with feathers, grain, hay or straw | Extrinsic allergic alveolitis diagnosed as caused by work involving the inhalation of organic dusts |
| Pneumoconioses caused by fibrogenic mineral dust (silicosis, anthraco-silicosis, asbestosis | Asbestosis Silicosi (Schedule 1 of the Workers’ Compensation (Dust Diseases) Act 1942) | Asbestosis, with or without mesothelioma Silicosis, with or without pulmonary tuberculosis | Exposure to mineral dust harmful to the lungs, including silica and asbestos | Asbestosis (any work involving exposure to inhalation of asbestos fibres) | Diseases caused by occupational exposure to asbestos are covered by the Asbestos-Related Diseases (Occupational Exposure) Compensation Act 2011 from 31 Oct 2011 | Asbestosis. Silicosis | Respiratory Diseases: Asbestosis Silicosis | As above – hard metal dust, and:
| Pneumoconioses caused by sclerogenic mineral dust (silicosis, anthraco-silicosis, asbestosis) and silico-tuberculosis, provided that silicosis is an essential factor causing the resultant incapacity or death |
| Pnemoconioses caused by non-fibrogenic mineral dust | Talcosis Berylliosis (Schedule 1 of the Workers’ Compensation (Dust Diseases) Act 1942) | N/A | Exposure to mineral dust harmful to the lungs, including silica and asbestos | Pneumonconiosis, including silicosis (any work involving mining, quarrying, cutting, crushing, grinding or pushing stone or melting, grinding or polishing metal) | Exposure to known causes of pneumoconiosis (including, but not limited to, beryllium, tin, iron oxide, barium, aluminium, cobalt and tungsten). | Pneumoconiosis involving exposure known to occasionally cause pneumoconiosis (for example beryllium, tin, iron oxide, barium, aluminium, cobalt or tungsten) | Respiratory Diseases - Other pneumoconiosis - All work exposures known to occasionally cause pneumoconiosis such as beryllium, tin, iron oxide, barium, aluminium, cobalt and tungsten | As above – hard metal dust. | Pneumoconiosis diagnosed as caused by tin, iron oxide, barium or cobalt |
| Silicotuberculosis | Silico-tuberculosis (Schedule 1 of the Workers’ Compensation (Dust Diseases) Act 1942) | Silicosis, with or without pulmonary tuberculosis | N/A | N/A | Pneumoconioses caused by silica dust (silicosis, anthracosilicosis) and silico-tuberculosis, provided that silicosis is an essential factor in causing the resultant incapacity or death from silico-tuberculosis | Silicosis – employment involving exposure to silica | Infectious Disease - Tuberculosis - persons with silicosis involved in contact with persons or animals in situations where tuberculosis prevalence is likely to be significantly higher than the general community | As above – hard metal dust. | Silico-tuberculosis |
| Other respiratory disease not mentioned in the preceding items | Asbestos related pleural diseases Asbestos induced carcinoma Mesothelioma Farmers lung (Schedule 1 Workers’ Compensation (Dust Diseases) Act 1942) | N/A | Diffuse pleural fibrosis, mesothelioma, and lung cancer where exposure is to asbestos. | N/A | N/A | Malignancy Larynx Malignancy – Lung Malignancy – Mesothelioma Extrinsic allergic alveolitis | Malignancy - Mesothelioma | Employment for at least 4 weeks (whether consecutive or not) involving work with an agent or thing specified in column 2 of an item of the table in Schedule 2. | N/A |
Skin Diseases | |||||||||
| Allergic contact dermatoses and contract urticaria caused by other recognised allergy-provoking agents arising from work activities not included in other items | N/A | N/A | Contact dermatitis (irritant and allergic) Employment for at least 4 weeks involving exposure to sensitising agents or irritants. | N/A | Contact dermatitis (irritant or allergenic) in workers exposed to sensitising agents or irritants (including, but not limited to, alcohols, cutting fluids, degreasers, disinfectants, petroleum products, soaps and cleaners, solvents, wet work, chromates, cobalt, cosmetics and fragrances, epoxy resin, latex, nickel, plants, preservatives, resins and acrylics). | Contact dermatitis (irritant and allergic) - employment involving exposure to sensitising agents or irritants | Skin Diseases - Contact dermatitis (irritant and allergenic) – All work involving sensitising agents or irritants | Employment for at least 4 weeks (whether consecutive or not) involving work and contact with:
| Occupational allergic contact dermatitis diagnosed as caused by recognised sensitising agents inherent in the work process such as, but not limited to, nickel and other metals, rubber additives, resins, petroleum distillates, solvents, soaps, detergents, and plant allergens |
| Vitiligo caused by other recognised agents arising from work activities not included in other items | N/A | N/A | Occupational vitiligo Employment for at least 4 weeks involving exposure to para-tertiary-butylphenol, para-tertiary-butylcatechol, para-amylphenol, hydroquinone or the monobenzyl or monobutyl ether of hydroquinone. | N/A | Occupational vitiligo in workers exposed to para-tertiary-butylphenol, para-tertiary-butylcatechol, para-amylphenol, hydroquinone or the monobenzyl, or monobutyl, ether of hydroquinone | Occupational vitiligo employment involving exposure to para-tertiary-butylphenol, para-tertiary-butylcatechol, para-amylphenol, hydroquinone, or the monobenzyl or monobutyl ether of hydroquinone | Skin Diseases - Occupational virtiligo – All work involving para-tertiary-butylphenol, para-tertiary- butylcatechol, para-amylphenol, hydroquinone, or the monobenzyl or monobutyl ether of hydroquinone | Employment for at least 4 weeks (whether consecutive or not) involving work with:
| Vitiligo diagnosed as caused by para-tertiary-butylphenol, para-tertiary-butylcatechol, para-amylphenol, hydroquinone, or the monobenzyl or monobutyl ether of hydroquinone |
| Other skin diseases caused by physical, chemical or biological agents at work not included in other items | N/A | Dermatitis venenata (contact with vegetable or mineral matter) | N/A Primary malignant disease of the skin (melanoma) Primary malignant disease of the skin (non‑melanoma) | Dermatitis (dust of blackwood) | N/A | N/A | N/A | N/A | N/A |
| Chronic tenosynovitis of hand and wrist due to repetitive movements, forceful exertions and extreme postures of the wrist | N/A | Tenosynovitis (inflammation of the tendon sheaths of the hand, wrists, forearm or elbow | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Olecranon bursitis due to prolonged pressure of the elbow region | N/A | Subcutaneous cellulitis or acute bursitis over the elbow (mining) | Bursitis (at the elbow or knee) Employment for at least 6 months involving prolonged external friction or pressure or repetitive motion at or about the elbow or the knee. | N/A | Bursitis of the Elbow employment involving prolonged external friction or pressure or repetitive motion at or about the elbow | Bursitis (at the elbow or knee) -employment involving prolonged external friction or pressure or repetitive motion at or about the elbow or the knee | Musculoskeletal Disease - Bursitis (at the elbow or knee) | Employment for at least 6 months (whether consecutive or not) involving a work activity that:
| N/A |
| Prepatellar bursitis due to prolonged stay in kneeling position | N/A | Subcutaneous cellulitis or acute bursitis arising at or about the knee (beat knee) (mining) | Bursitis (at the elbow or knee) Employment for at least 6 months involving prolonged external friction or pressure or repetitive motion at or about the elbow or the knee. | N/A | Bursitis of the Knee employment involving prolonged external friction or pressure or repetitive motion at or about the elbow or the knee | Bursitis of the Knee employment involving prolonged external friction or pressure or repetitive motion at or about the elbow or the knee | Musculoskeletal Disease - Bursitis (at the elbow or knee) | As above. | N/A |
1Unless otherwise specified occupational diseases listed in Table 1 are specified in the Workers Rehabilitation and Compensation (Deemed Diseases) Notice 2017
2 Includes Seacare.